Reduce Manual Work by 90% with Cydem VT

Screen clones faster under conditions close to biomanufacturing production, all while regularly collecting vital data on cell growth and productivity along the way.
Danaher Corporation

Cydem VT Automated Clone Screening System

High Throughput

96 x 5 mL parallel microbioreactors

Early Insights

Regular on-deck cell count, viability and titer measurements throughout the entire cultivation

Full Automation

Less manual work and human error; reduced risk of contamination

Innovating to Solve Your Cell Line Development Pain Point

Danaher Corporation

Accelerate your Cell Line Development Process

The Cydem VT Automated Clone Screening System is an integrated platform comprised of a bioreactor, onboard analytics, automated liquid handling and validated cell viability and monoclonal antibody titer measurement. Optimize your clone screening using the new Cydem VT system with pH-controlled, fed-batch conditions and individual gassing regulation (CO2 & dissolved oxygen) in each parallel microbioreactor to select your clones with more confidence.

Earlier insights, high throughput, reduced hands-on time

Danaher Corporation

Danaher Corporation

Viability and online titer of 10 selected clones showing different performance (low, mid, and high) during a 14-day fed-batch cultivation.

Experience the Power of One!

Danaher Corporation

For Research Use Only. Not for use in diagnostic procedures.

Speak to one of our world-leading life sciences experts

id
TTAE
name
TTAE
_clientID
546006278
_deExternalKey
TTAE
_action
add
_returnXML
1
Inquiry_Type
Talk to an Expert
_successURL
https://stage.lifesciences.danaher.com/us/en/solutions/mabs/cell-line-development.html
_errorURL
https://help.salesforce.com/s/articleView?id=sf.mc\_es\_demanager.htm